Juxtapid, Lojuxta (lomitapide) is a small molecule pharmaceutical. Lomitapide was first approved as Juxtapid on 2012-12-21. It is used to treat hypercholesterolemia in the USA. It has been approved in Europe to treat hypercholesterolemia. Juxtapid's patents are valid until 2027-08-19 (FDA).
|Drug Class||Microsomal triglyceride transfer protein (MTP) inhibitors|